Variable | Pre IAC-introduction (n = 251) | Post IA- introduction (n = 249 | P-value |
---|---|---|---|
Age in years, mean (SD) | 36.5 (13.4) | 33.1 (12.0) | 0.0028 |
Sex | Â | Â | 0.619 |
 Male | 90 (35.7) | 84 (33.7) |  |
 Female | 161 (64.1) | 165 (66.3) |  |
Marital status | Â | Â | 0.962 |
 Married | 129 (51.4) | 131 (52.6) |  |
 Single | 101 (40.2) | 98 (39.4) |  |
 Children | 21 (8.4) | 20 (8.0) |  |
CD4, median (IQR) | 180 (85–310) | 261.5 (118–452) |  < 0.001 |
CD4 | Â | Â | 0.006 |
 500 and less | 191 (89.7) | 155 (79.9) |  |
 > 500 | 22 (10.3) | 39 (20.1) |  |
First viral load, median (IQR) | 13,551 (2851–47,095) | 2298.5 (0–26,508) |  < 0.001 |
Initial regimen |  |  |  < 0.001 |
 Efavirenz-based regimen | 130 (51.8) | 187 (75.1) |  |
 Non-Efavirenz-based regimen | 121 (48.2) | 62 (24.9) |  |
Current regimen |  |  |  < 0.001 |
 NNRTI | 42 (16.7) | 68 (27.3) |  |
 Protease Inhibitors | 179 (71.3) | 135 (54.2) |  |
 DTG-based regimen | 30 (12.0) | 46 (18.5) |  |
Regimen switching |  |  |  < 0.001 |
 0 | 73 (29.1) | 124 (49.8) |  |
 1 | 174 (69.3) | 124 (49.8) |  |
 2 | 4 (1.6) | 1 (0.4) |  |
First detectable viral load, median (IQR) | 20,782 (20,669–20,847) | 21,206 (21,017–21,390) |  < 0.001 |
Days on ART, median (IQR) | 878.5 (395–1471) | 988.5 (336–1595) | 0.648 |